Related Experiment Video
Updated: Jan 7, 2026
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With
Lucile Sesé1,2,3, Isabella Annesi-Maesano4, Pierre Antoine Juge5
1Service de Physiologie, APHP, Hôpital Avicenne, Bobigny, France.
Background And Objective:
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and idiopathic pulmonary fibrosis share common risk factors, including the MUC5B promoter variant (rs35705950). We examined the contribution of air pollutants to ILD risk in an RA population and assessed the modifying effect of genetic susceptibility.
Methods:
This study included patients with RA who had undergone chest HRCT. MUC5B status was collected when available. Exposure levels to NO2, PM10, and PM2.5 were estimated based on residential postal code using a dispersion model. Logistic regression analysed the influence of air pollution on ILD occurrence, and the interaction between air pollution and MUC5B status was evaluated.
Results:
We included 594 patients with RA (mean age: 58 ± 12 years, 71% women, 44% current or ex-smokers), of whom 227 (38%) had ILD and 292 patients were genotyped for MUC5B rs35705950. Increased long-term exposure to NO2 (OR: 1.04 [1.01-1.06]), PM2.5 (OR: 1.11 [1.10-1.24]), and PM10 (OR: 1.15 [1.05-1.26]) was associated with ILD, after adjusting for age, sex, smoking status and HRCT year. A negative interaction between PM10/PM2.5 exposure and the T allele suggested pollution's effect on ILD risk was attenuated in the presence of the minor T allele.
Conclusion:
Long-term exposure to air pollution is an independent risk factor for RA-ILD and its effect may be modified according to MUC5B rs35705950 genotype.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:29Asthma-I: Introduction
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...